NASDAQ:NERV • US6033802058
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MINERVA NEUROSCIENCES INC (NERV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2022-11-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-10-17 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-03-04 | HC Wainwright & Co. | Maintains | Buy |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.18M | 339.997K -100.00% | 19.506M | 81.965M 320.20% | 223.77M 173.01% | 279.48M 24.90% | |||||||||
| EBITDA YoY % growth | -51.71M -25.63% | -75.85M -46.68% | 1.87M 102.47% | N/A -2,526.20% | N/A 44.41% | N/A 8.45% | N/A 4.81% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -51.73M -25.65% | -75.87M -46.67% | 1.85M 102.44% | -32.323M -2,552.43% | -26.164M 44.39% | -21.42M 8.36% | -24.151M 4.84% | -14.824M 32.62% | -36.722M -147.71% | -47.349M -28.94% | -37.697M 20.39% | 4.329M 111.48% | 99.515M 2,198.80% | 78.54M -21.08% | |
| Operating Margin | N/A | N/A | 4.49% | -9,506.80% | N/A | N/A | N/A | N/A | N/A | N/A | -193.26% | 5.28% | 44.47% | 28.10% | |
| EPS YoY % growth | -10.32 -18.35% | -14.88 -44.19% | 0.40 102.69% | -6.96 -2,400.00% | -4.56 34.57% | -4.35 19.44% | -0.31 31.55% | -1.62 51.15% | -0.81 50.00% | -0.62 23.90% | -0.26 58.68% | 0.62 344.00% | 1.81 190.16% | 14.74 716.38% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 73.48% | -0.18 57.30% | -0.22 40.28% | -0.22 65.73% | -0.11 15.38% | -0.12 33.33% | -0.12 44.19% | -0.13 39.53% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.712M -46.35% | -8.16M -141.84% | -11.526M -305.22% | -14.382M -188.70% | -14.688M -157.14% | -14.994M -83.75% | -12.24M -6.19% | -10.506M 26.95% |
All data in USD
7 analysts have analysed NERV and the average price target is 7.4 USD. This implies a price increase of 42.76% is expected in the next year compared to the current price of 5.18.
MINERVA NEUROSCIENCES INC (NERV) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of MINERVA NEUROSCIENCES INC (NERV) is -0.13 USD and the consensus revenue estimate is 0 USD.
The consensus rating for MINERVA NEUROSCIENCES INC (NERV) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.